Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same author

Base editing-derived models of human WDR34 and WDR60 disease alleles replicate retrograde intraflagellar transport (IFT) and hedgehog signaling defects.

Communications biology·2026
Same author

LRBA regulates actin cytoskeleton dynamics through NMIIA during B cell immune responses.

EMBO reports·2026
Same author

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.

Molecular therapy. Advances·2026
Same author

Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation.

Cell stem cell·2026
Same author

Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor.

Nature communications·2026

Related Experiment Video

Updated: Jul 10, 2026

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

Targeted genome modifications using integrase-deficient lentiviral vectors.

Tatjana I Cornu1, Toni Cathomen

  • 1Charité Medical School, Institute of Virology (CBF), Berlin, Germany.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|November 14, 2007
PubMed
Summary

This study introduces a novel gene correction system using integrase-deficient lentiviral vectors (IDLVs) to repair mutations via homologous recombination (HR). This method achieves stable gene correction in human cells, offering precise genetic modification capabilities.

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

Related Experiment Videos

Last Updated: Jul 10, 2026

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Genetics

Background:

  • Gene correction offers a promising therapeutic strategy by directly repairing defective genes within the cellular genome.
  • Achieving sustained and tissue-specific expression of corrected genes via endogenous promoters remains a challenge.

Purpose of the Study:

  • To develop and validate a novel gene correction system utilizing integrase-deficient lentiviral vectors (IDLVs).
  • To demonstrate the efficacy of IDLVs in facilitating homologous recombination (HR)-mediated gene repair for endogenous mutations.

Main Methods:

  • Development of a gene correction system employing IDLVs encoding a repair template.
  • Co-delivery of the IDLV repair template with an I-SceI nuclease expression vector to induce targeted double-strand breaks.
  • Proof-of-concept study using a defective enhanced green fluorescent protein (EGFP) gene as a target locus.

Main Results:

  • Stable gene correction was achieved in up to 12% of cells, influenced by vector dose, nuclease levels, and cell type.
  • Genotypic analyses confirmed successful homologous recombination (HR) between the target locus and the IDLV repair template.
  • The induced double-strand break was critical for stimulating IDLV-mediated gene repair.

Conclusions:

  • Integrase-deficient lentiviral vectors (IDLVs) represent a viable tool for precise and permanent genetic modifications in human cells.
  • The developed IDLV system effectively leverages homologous recombination for gene correction.
  • This approach holds potential for advancing gene therapy applications requiring endogenous gene repair.